Inactive Instrument
Asarina Pharma AB Stock
Stocks
ASAP
SE0011641794
Biotechnology & Medical Research
OTC Markets Traded| 1 day | -31.03% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | 71 | 2017-03-31 | |
Magnus Brisander
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Paul de Potocki
CHM | Chairman | 64 | 2017-12-31 |
Marianne Kock
BRD | Director/Board Member | 71 | 2017-12-31 |
| Director/Board Member | 52 | 2020-01-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -31.03% | -40.43% | - | - | 64.67K | ||
| +5.04% | +3.27% | +50.62% | +105.43% | 66.93B | ||
| +1.64% | -0.18% | +36.02% | +76.81% | 61.97B | ||
| -3.15% | +0.06% | -12.70% | +368.54% | 28.26B | ||
| +4.55% | -0.08% | +34.70% | +17.28% | 24.59B | ||
| +2.69% | +0.85% | +1.66% | -12.57% | 24.3B | ||
| +1.15% | -1.17% | +18.94% | -21.92% | 19.41B | ||
| -7.03% | -9.16% | +161.91% | +303.00% | 16.77B | ||
| +3.44% | -1.68% | -5.00% | +541.17% | 14.18B | ||
| +4.50% | +6.02% | -3.27% | +859.16% | 14B | ||
| Average | -1.84% | -3.94% | +31.43% | +248.54% | 30.05B | |
| Weighted average by Cap. | +2.00% | -2.84% | +33.73% | +172.73% |
Employees
6
















